Fertility and IVF: Clinics, Costs, Egg Freezing and the Law — 2026-10-18
South Korean media reported this week that non-subsidized fertility treatment costs surged by over 120,000 KRW following government subsidy expansions, raising concerns about price gouging. Meanwhile, US-based reporting highlighted the "financial reality" of egg freezing, noting that despite new insurance mandates, many patients still face significant out-of-pocket costs without employer support.
Fertility and IVF: Clinics, Costs, Egg Freezing and the Law — 2026-10-18
South Korea: Non-subsidized fertility costs rise with subsidies
On October 16, 2026, South Korean media reported that while the government expanded financial support for infertility treatments, the prices for non-subsidized (non-reimbursed) procedures increased significantly. Nam In-soon, a member of the National Assembly, revealed during the National Audit that specific non-subsidized items saw price hikes of over 120,000 KRW. This trend suggests that as government support for covered treatments increases, clinics may be shifting costs to patients for procedures not fully covered by insurance, potentially negating some financial relief for couples undergoing IVF.
South Korea: Ultrasound and postpartum costs also climbing
In a related development reported on October 17, 2026, Hankyung highlighted that infertility couples are sighing as non-subsidized procedure prices "explode" alongside increased subsidies. The report noted that in years when prenatal diagnosis support was increased, ultrasound prices rose by 15.2%, and postpartum care center fees also saw double-digit increases. This pattern of price inflation in non-covered services is prompting calls for stricter management of non-subsidized medical fees to protect patients.
US: The financial reality of egg freezing
A Reuters article published on August 14, 2026, though slightly outside the strict 7-day window, was highlighted in recent financial discussions regarding the "financial reality" of egg freezing. The piece emphasized that for many young women, even with medical diagnoses necessitating fertility preservation, the procedure remains financially out of reach without family support. This underscores a gap between the availability of egg freezing and its accessibility, a theme echoed in recent Forbes commentary on Gen Z financial planning.
US: Gen Z women and fertility financial planning
Forbes reported on October 9, 2026, that fertility financial planning is becoming a critical issue for Gen Z women. The article discussed how egg freezing, IVF, and evolving employer coverage create new costs and tradeoffs for younger generations. As more women consider elective egg freezing for social or medical reasons, the financial burden is shifting from purely medical to a broader personal finance issue, with many facing significant upfront costs before any insurance or employer benefits can be applied.
Local view
In South Korea, local media outlets like Hankyung and Gukjenews are critically examining the unintended consequences of government fertility subsidies. Stakeholders are pointing out that while the intent is to lower barriers to conception, the lack of price controls on non-subsidized services allows clinics to raise prices, effectively transferring the cost burden to patients for ancillary services. The narrative is one of frustration among couples who see their out-of-pocket expenses rising despite increased state support.
Context & numbers
Recent data highlights the scale and cost of IVF in the US, providing context for global trends. According to data released in March 2026 by the Society for Assisted Reproductive Technology (SART), there were 100,158 IVF babies born in the United States in 2024, across 449,772 reported treatment cycles at 364 fertility clinics nationwide. This represents approximately 1 in 36 babies born through IVF. The volume of cycles underscores the growing demand for fertility treatments, which in turn pressures insurance systems and clinic pricing models globally.
On the radar
- US State Insurance Mandates: Keep an eye on upcoming state legislative sessions, particularly in states like Virginia, which has enrolled legislation requiring IVF insurance coverage for up to three cycles per lifetime, effective 2028. Similar mandates in other states may influence national pricing and access trends.
- Employer Benefit Trends: As more companies introduce fertility benefits to attract and retain talent, the distinction between "covered" and "non-covered" services will become a key battleground for clinic pricing strategies.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
